MIR497HG‐Derived miR‐195 and miR‐497 Mediate Tamoxifen Resistance via PI3K/AKT Signaling in Breast Cancer
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
MIR497HG‐Derived miR‐195 and miR‐497 Mediate Tamoxifen Resistance via PI3K/AKT Signaling in Breast Cancer
Authors
Keywords
-
Journal
Advanced Science
Volume 10, Issue 12, Pages -
Publisher
Wiley
Online
2023-02-23
DOI
10.1002/advs.202204819
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Nexus between PI3K/AKT and Estrogen Receptor Signaling in Breast Cancer
- (2021) Aditi S. Khatpe et al. Cancers
- Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2021) Hyuna Sung et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Interferon regulatory factor 1 (IRF-1) downregulates Checkpoint kinase 1 (CHK1) through miR-195 to upregulate apoptosis and PD-L1 expression in Hepatocellular carcinoma (HCC) cells
- (2021) Yihe Yan et al. BRITISH JOURNAL OF CANCER
- Novel LncRNA OXCT1-AS1 indicates poor prognosis and contributes to tumorigenesis by regulating miR-195/CDC25A axis in glioblastoma
- (2021) Chen Zhong et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Evidence-based approaches for the management of side-effects of adjuvant endocrine therapy in patients with breast cancer
- (2021) Maria Alice Franzoi et al. LANCET ONCOLOGY
- MicroRNA-497/195 is tumor-suppressive and cooperates with CDKN2A/B in pediatric acute lymphoblastic leukemia
- (2021) Elena Boldrin et al. BLOOD
- LINC00665 promotes breast cancer progression through regulation of the miR-379-5p/LIN28B axis
- (2020) Wei Ji et al. Cell Death & Disease
- Overcoming Endocrine Resistance in Breast Cancer
- (2020) Ariella B. Hanker et al. CANCER CELL
- The network of non-coding RNAs and their molecular targets in breast cancer
- (2020) Francesca Crudele et al. Molecular Cancer
- ZNF281-miR-543 Feedback Loop Regulates Transforming Growth Factor-β-Induced Breast Cancer Metastasis
- (2020) Wei Ji et al. Molecular Therapy-Nucleic Acids
- Genome‐wide cooperation of EMT transcription factor ZEB 1 with YAP and AP ‐1 in breast cancer
- (2020) Nora Feldker et al. EMBO JOURNAL
- Long non-coding RNA CASC9 promotes tumor growth and metastasis via modulating FZD6/Wnt/β-catenin signaling pathway in bladder cancer
- (2020) Yonghao Zhan et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Akt-targeted therapy as a promising strategy to overcome drug resistance in breast cancer – A comprehensive review from chemotherapy to immunotherapy
- (2020) Parham Jabbarzadeh Kaboli et al. PHARMACOLOGICAL RESEARCH
- Emerging roles of long non-coding RNAs in breast cancer biology and management
- (2020) I. Amelio et al. SEMINARS IN CANCER BIOLOGY
- EMT, MET, Plasticity, and Tumor Metastasis
- (2020) Basil Bakir et al. TRENDS IN CELL BIOLOGY
- Enhancer-Driven lncRNA BDNF-AS Induces Endocrine Resistance and Malignant Progression of Breast Cancer through the RNH1/TRIM21/mTOR Cascade
- (2020) Xiaorong Lin et al. Cell Reports
- Targeting the PI3K/AKT/mTOR Pathway in Hormone-Positive Breast Cancer
- (2020) Sara E. Nunnery et al. DRUGS
- Micro RNA ‐195 controls MICU 1 expression and tumor growth in ovarian cancer
- (2020) Geeta Rao et al. EMBO REPORTS
- Methylation-Mediated Silencing of MicroRNA-497 Promotes Breast Cancer Progression Through Up-Regulation of Mucin1
- (2020) Shuang Tao et al. Frontiers in Oncology
- Pseudogene KRT17P3 drives cisplatin resistance of human NSCLC cells by modulating miR‐497‐5p/mTOR
- (2020) Zhibo Hou et al. CANCER SCIENCE
- Targeted inhibition of ERα signaling and PIP5K1α/Akt pathways in castration‐resistant prostate cancer
- (2020) Julius Semenas et al. Molecular Oncology
- The crucial role of epigenetic regulation in breast cancer anti-estrogen resistance: Current findings and future perspectives
- (2020) Olga A. Sukocheva et al. SEMINARS IN CANCER BIOLOGY
- Silencing of lncRNA MIR497HG via CRISPR/Cas13d Induces Bladder Cancer Progression Through Promoting the Crosstalk Between Hippo/Yap and TGF-β/Smad Signaling
- (2020) Changshui Zhuang et al. Frontiers in Molecular Biosciences
- miR-190 enhances endocrine therapy sensitivity by regulating SOX9 expression in breast cancer
- (2019) Yue Yu et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Measurement of Urinary Level of a Specific Competing endogenous RNA network (FOS and RCAN mRNA/ miR-324-5p, miR-4738-3p, /lncRNA miR-497-HG) Enables Diagnosis of Bladder Cancer
- (2019) Sanaa Eissa et al. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS
- Emerging role of histone deacetylase inhibitors as anti-breast-cancer agents
- (2019) Meran Keshawa Ediriweera et al. DRUG DISCOVERY TODAY
- The long noncoding RNA H19 promotes tamoxifen resistance in breast cancer via autophagy
- (2019) Ji Wang et al. Journal of Hematology & Oncology
- SNHG5 Promotes Breast Cancer Proliferation by Sponging the miR-154-5p/PCNA Axis
- (2019) Jiang-Rui Chi et al. Molecular Therapy-Nucleic Acids
- Overview of the relevance of PI3K pathway in HR-positive breast cancer
- (2019) N Vasan et al. ANNALS OF ONCOLOGY
- The Role of Non-coding RNAs in Oncology
- (2019) Frank J. Slack et al. CELL
- Advances in Endocrine-Based Therapies for Estrogen Receptor-Positive Metastatic Breast Cancer
- (2019) Vassilis Aggelis et al. DRUGS
- MiR‐195 and miR‐497 suppress tumorigenesis in lung cancer by inhibiting SMURF2‐induced TGF‐β receptor I ubiquitination
- (2019) Dong‐Kyu Chae et al. Molecular Oncology
- Targeting miRNAs by histone deacetylase inhibitors (HDACi): Rationalizing epigenetics-based therapies for breast cancer
- (2019) Meran Keshawa Ediriweera et al. PHARMACOLOGY & THERAPEUTICS
- Tumor‐associated macrophages secrete CC‐chemokine ligand 2 and induce tamoxifen resistance by activating PI3K/Akt/mTOR in breast cancer
- (2019) Dongbo Li et al. CANCER SCIENCE
- miR-190 suppresses breast cancer metastasis by regulation of TGF-β-induced epithelial–mesenchymal transition
- (2018) Yue Yu et al. Molecular Cancer
- The Genomic Landscape of Endocrine-Resistant Advanced Breast Cancers
- (2018) Pedram Razavi et al. CANCER CELL
- Expression and clinicopathological significance of DNA methyltransferase 1, 3A and 3B in tamoxifen-treated breast cancer patients
- (2018) Rosa Jahangiri et al. GENE
- lncRNA MIR100HG-derived miR-100 and miR-125b mediate cetuximab resistance via Wnt/β-catenin signaling
- (2017) Yuanyuan Lu et al. NATURE MEDICINE
- Blocking MIR155HG/miR-155 axis inhibits mesenchymal transition in glioma
- (2017) Xuechao Wu et al. NEURO-ONCOLOGY
- ZEB1 induces ER-α promoter hypermethylation and confers antiestrogen resistance in breast cancer
- (2017) Jianbo Zhang et al. Cell Death & Disease
- SSRP1 Contributes to the Malignancy of Hepatocellular Carcinoma and Is Negatively Regulated by miR-497
- (2016) Qianshan Ding et al. MOLECULAR THERAPY
- Analysis of MiR-195 and MiR-497 Expression, Regulation and Role in Breast Cancer
- (2011) D. Li et al. CLINICAL CANCER RESEARCH
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started